Probiotics reduce complications induced by interventional therapy in patients with primary hepatic carcinoma and liver cirrhosis
10.3760/cma.j.issn.1674-2397.2009.06.005
- VernacularTitle:益生菌制剂可减少原发性肝癌合并肝硬化患者介入术后并发症的发生
- Author:
Yutang CHEN
;
Guoliang SHAO
;
Lei SHI
;
Zheng YAO
;
Qirong XIA
- Publication Type:Journal Article
- Keywords:
Carcinoma,bepatocellular;
Probiotics;
Transarterial chemoembelization
- From:
Chinese Journal of Clinical Infectious Diseases
2009;02(6):337-340
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate whether oral administration of probiotics can reduce complications induced by interventional therapy in patients with primary hepatic carcinoma and liver cirrosis.Methods Two hundred and sixty four patients with primary hepatic carcinoma and liver cirrhosis who underwent transarterial chemoembolization(TACE) were randomly divided into two groups.and patients in experimental group were given probiotics but not in control group.Shoa-term clinical manifestations.liver functions,blood routine and pain scores were compared between two groups.Results On the day 3 after therapy,the incidence of abdominal distension and constipation in experimental group were less than that in control group(x2=18.22 and 55.22,P=0.000);On the day 7 after therapy,the incidence of abdominal distension,constipation and infection in experimental group were less than that in control group(x2=5.35,13.5 and 19.14,P=0.021,0.000 and 0.000).There were no significant difference in other clinical manifestations,liver function,blood routine and pain scores between the two groups. Conclusion Oral administration of probiotics can reduce the incidence of some short-term complication induced by interventional therapy in patients with hepatic carcinoma and liver cirrhosis.
